The mammalian heart has a limited regenerative potential due to the low proliferation rate of adult cardiomyocytes. However, a narrow regenerative window has been identified in the neonatal murine heart, wherein mice are able to successfully regenerate their hearts both at the tissue and functional level following injury. In a cross-species transcriptomic screen in the Lee laboratory, inflammatory response genes including complement receptors were upregulated in a conserved manner in the regenerating heart of three model organisms ? axolotl, mouse and zebrafish. The most-upregulated inflammatory response genes include G-protein coupled receptors (GPCR) for complement components, complement 5a receptor (C5aR1) and complement 3a receptor (C3aR). The complement system is part of the innate immune system and functions to clear foreign material. Activation of an early immune response is a shared feature observed in the regenerating heart of model organisms, consistent with the upregulation of C5aR1 and C3aR observed. C5aR1 is a GPCR that functions as a complement receptor for C5a, generated by proteolytic cleavage of complement component 5. Pharmacologic inhibition of C5aR1 after apical resection results in an impaired cardiomyocyte proliferative response in all three model organisms studied ? axolotl, mouse and zebrafish. I propose to investigate the role of complement activation in murine cardiac regeneration, to elucidate the molecular mechanisms that initiate effective repair and cardiomyocyte proliferation in the mammalian heart following injury. To understand the role of C5aR1, I will utilize global genetic deletion mouse model of C5aR1 to assess cardiac regeneration after apical resection at the cellular, tissue and functional level in C5aR1 wild-type and C5aR1 knock-out mice. I propose to assess cardiomyocyte proliferation in C5aR1 wild-type and knock-out mice to understand the sequence of molecular events in the injured heart that initiate cardiomyocyte proliferation and effective regeneration. Furthermore, I will investigate the role of C3aR in early cardiac regeneration using pharmacologic inhibition and C3aR knock-out mice. In addition, I will perform experiments in non-regenerative murine models (7- day-old mice) to investigate if acute activation of complement signaling (C3 and C5) will increase cardiomyocyte proliferation following injury. These studies will likely define a mechanistic pathway of early events critical for the initiation of cardiomyocyte proliferation in the myocardium.
Heart disease is a major cause of adult mortality in the United States, because, the adult heart is unable to regenerate significant amounts of tissue after an injury. Understanding how model organisms achieve heart regeneration by identifying evolutionarily conserved pathways that initiate cell division in the heart will provide information on how to initiate successful heart regeneration after an injury in mammals. Therefore, I propose to investigate the role of the innate immune system in cardiac regeneration.
